A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma

Gounder, M. M., Rosenbaum, E., Wu, N., Dickson, M. A., Sheikh, T. N., D’Angelo, S. P., Chi, P., Keohan, M. L., Erinjeri, J. P., Antonescu, C. R., Agaram, N., Hameed, M. R., Martindale, M., Lefkowitz, R. A., Crago, A. M., Singer, S., Tap, W. D., Takebe, N., Qin, L.-X., & Schwartz, G. K. (2022). A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma. Clinical Cancer Research, 28(8), 1586–1594. https://doi.org/10.1158/1078-0432.ccr-21-3874
Authors:
Mrinal M. Gounder
Evan Rosenbaum
Nian Wu
Mark A. Dickson
Tahir N. Sheikh
Sandra P. D'Angelo
Ping Chi
Mary Lou Keohan
Joseph P. Erinjeri
Cristina R. Antonescu
Narasimhan Agaram
Meera R. Hameed
Moriah Martindale
Robert A. Lefkowitz
Aimee M. Crago
Sam Singer
William D. Tap
Naoko Takebe
Li-Xuan Qin
Gary K. Schwartz
Affiliated Authors:
Tahir N. Sheikh
Gary K. Schwartz
Publication Type:
Article
Unique ID:
10.1158/1078-0432.CCR-21-3874
PMID:
Publication Date:
Data Source:
Scopus

Record Created: